Human TNFRSF13B ELISA Kit (V2LY-0626-LY5737)
Compare
Online Inquiry
Basic Information
- Pre-coated ELISA Plate: 12 wells * 8 detachable strips
- Standard solution: 0.5ml x1
- Standard diluent: 3ml x1
- Streptavidin-HRP: 6ml x1
- Stop solution: 6ml x1
- Substrate solution A: 6ml x1
- Substrate solution B: 6ml x1
- Wash buffer concentrate (25x): 20ml x1
- Biotinylated antibody: 1ml x1
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Biological Process B cell homeostasis Source:GO_Central1 Publication
Biological Process cell surface receptor signaling pathway Source:ProtInc1 Publication
Biological Process hematopoietic progenitor cell differentiation Source:GO_Central1 Publication
Biological Process negative regulation of B cell proliferation Source:GO_Central1 Publication
A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low.
Immunoglobulin A deficiency 2 (IGAD2):
Selective deficiency of immunoglobulin A (IGAD) is the most common form of primary immunodeficiency, with an incidence of approximately 1 in 600 individuals in the western world. Individuals with symptomatic IGAD often have deficiency of IgG subclasses or decreased antibody response to carbohydrate antigens such as pneumococcal polysaccharide vaccine. Individuals with IGAD also suffer from recurrent sinopulmonary and gastrointestinal infections and have an increased incidence of autoimmune disorders and of lymphoid and non-lymphoid malignancies. In vitro studies have suggested that some individuals with IGAD have impaired isotype class switching to IgA and others may have a post-switch defect. IGAD and CVID have been known to coexist in families. Some individuals initially present with IGAD1 and then develop CVID. These observations suggest that some cases of IGAD and CVID may have a common etiology.
Helical: 166-186
Cytoplasmic: 187-293
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
$30 eGift Card
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Alternative Versions
Human Recombinant TACI protein, ECD, hFc Tag (CAT#: V2LY-0526-LY7044)
Human Recombinant TACI protein, hFc Tag (CAT#: V2LY-0526-LY7046)
Cynomolgus Recombinant TNFRSF13B protein, His Tag (CAT#: V2LY-0526-LY1649)
TNFRSF13B Matched Antibody Pair (1218) (CAT#: APMAB-1218LY)
Antibody Pairs
TNFRSF13B Matched Antibody Pair (1218) (CAT#: APMAB-1218LY)
Related Products
Rat Anti-Tnfrsf13b Recombinant Antibody (CBYJT-3727) (CAT#: CBMAB-T3107-YJ)
Mouse Anti-TNFRSF13B Recombinant Antibody (CBYJT-3725) (CAT#: CBMAB-T3105-YJ)
Mouse Anti-TNFRSF13B Recombinant Antibody (CBYJT-3718) (CAT#: CBMAB-T3098-YJ)
Mouse Anti-TNFRSF13B Recombinant Antibody (2C3) (CAT#: CBMAB-A9276-LY)
Mouse Anti-TNFRSF13B Recombinant Antibody (CBYJT-3721) (CAT#: CBMAB-T3101-YJ)
Mouse Anti-TNFRSF13B Recombinant Antibody (4C4) (CAT#: CBMAB-A9281-LY)
Mouse Anti-TNFRSF13B Recombinant Antibody (CBYJT-3719) (CAT#: CBMAB-T3099-YJ)
Mouse Anti-TNFRSF13B Recombinant Antibody (1G11) (CAT#: CBMAB-A9274-LY)
Human Recombinant TACI protein, hFc Tag (CAT#: V2LY-0526-LY7046)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
